-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$32.001593.12% Upside
HilleVax, Inc. Frequently Asked Questions
-
What analysts cover HilleVax, Inc.?
HilleVax, Inc. has been rated by research analysts at Stifel Nicolaus, Leerink Partners in the past 90 days.